Study finds 2K documents with patient info dumped in recycling bins at hospitals

Records containing personal health information (PHI) and personally identifiable information (PII) were found in the recycling at five different hospitals, according to a study published March 20 in JAMA.

In this study, led by Nancy Baxter, MD, PhD, at the University of Toronto, researchers audited five teaching hospital in Toronto form November 2014 to 2016 for the amount of PII and PHI disposed in recycling bins.

Although all five hospitals had policies for paper disposal, researchers found documents containing PII and PHI in the recycling of all hospitals. Of the 2,687 documents with PII and PHI information, 802 were low sensitivity, 843 were medium and 1,042 were high. Most documents were found at physicians’ offices with clinical notes, summaries and medical report being the most frequent type of PII document being discarded.

“A substantial amount of personal information, most of it PHI, was found in the recycling at 5 teaching hospitals in Toronto, Ontario, despite institutional policies in place for protection of personal information. Little is known about the prevalence of privacy breaches in hospitals,” wrote Baxter and colleagues. “Studies have focused primarily on privacy risks related to electronic records; however, migration to the EHR may have heightened risks of other privacy breaches. The frequent presence of PII and PHI in recycling at these institutions indicates potential privacy breaches is not isolated. [It] should be expected in locations where patient information is printed and there is an option for nonconfidential paper disposal.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.